Icecure Medical Ltd reports results for the quarter ended June 30 - Earnings Summary

Icecure Medical

12/08/2026 14:31

Icecure Medical Ltd ICCM.OQ reported a quarterly adjusted loss of $3.11​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of $-1.80.  The mean expectation of three analysts for the quarter was for a loss of $1.50 per share. Wall Street expected results to range from $-1.80 to -90 cents per share.
Revenue rose 72.8% to $907.00 thousand from a year ago; analysts expected $1.45 million. 
Icecure Medical Ltd's reported EPS for the quarter was a loss of $3.11​.
The company reported a quarterly loss of $4.5 million.
Icecure Medical Ltd shares had fallen by 27.8% this quarter and lost 80.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Icecure Medical Ltd is $30.00, about 88.3% above its last closing price of $3.51
This summary was machine generated from LSEG data August 12 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-1.50
-3.11
Missed
Mar. 31 2026 
-1.40
-1.80
Missed
Dec. 31 2025 
-1.35
-2.10
Missed
Sep. 30 2025 
-1.50
-1.80
Missed